SCHEMBL6614508

SCHEMBL6614508

COc1ccc(-c2cc(=O)c3ccc(O)c(O)c3o2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 10/20 0.73
▸ CYP3A4 P08684 5/20 0.68
▸ ALDH1A1 P00352 5/20 0.68
▸ MAPT P10636 5/20 0.68
▸ TP53 P04637 4/20 0.68
▸ MEN1 O00255 4/20 0.68
▸ HPGD P15428 4/20 0.68
▸ KMT2A Q03164 4/20 0.68
▸ KDM4E B2RXH2 3/20 0.68
▸ HSD17B10 Q99714 3/20 0.68
▸ MAPK1 P28482 3/20 0.68
▸ MAOB P27338 2/20 0.68
▸ ALOX15 P16050 2/20 0.68
▸ BRD4 O60885 1/20 0.68
▸ IKBKB O14920 1/20 0.68
▸ CYP19A1 P11511 1/20 0.68
▸ MAOA P21397 1/20 0.68
▸ NTRK2 Q16620 1/20 0.68
▸ SMN1; SMN2 Q16637 1/20 0.68
▸ POLB P06746 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618581 0.88 TUBB4A (0.67) TERTCYP3A4ALDH1A1MAPTTP53
SCHEMBL6613017 0.85 TERT (0.88) TERTCYP3A4ALDH1A1MAPTMEN1
SCHEMBL31322174 0.84 TERT (1.00) TERTCYP3A4ALDH1A1MAPTTP53
SCHEMBL4649959 0.84 TERT (1.00) TERTCYP3A4ALDH1A1MAPTTP53
SCHEMBL1778286 0.84 TERT (1.00) TERTCYP3A4ALDH1A1MAPTTP53
SCHEMBL6614126 0.84 TERT (1.00) TERTCYP3A4ALDH1A1MAPTTP53
SCHEMBL6613428 0.84 TERT (0.81) TERTCYP3A4ALDH1A1MAPTTP53
SCHEMBL6618127 0.82 TERT (0.78) TERTCYP3A4ALDH1A1MAPTTP53
SCHEMBL6802044 0.82 TERT (0.77) TERTCYP3A4ALDH1A1MAPTTP53
7,8-Dihydroxyflavone SCHEMBL419316 0.81 TERT (1.00) TERTCYP3A4ALDH1A1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 — — US disclosed
EP-1373244-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-02 — — EP disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 — — US disclosed
WO-2002074036-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-09-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885CYP3A4 3385/4885ALDH1A1 1247/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885CYP3A4 3411/4885ALDH1A1 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback